Search

everythinglearnresearchcommunity

for

Search:↓

Higher fasting insulin levels increase the risk of androgenetic alopecia.

A specific gene mutation causes long hair in Angora rabbits.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

BLIMP1 is essential for skin maintenance but not for defining sebaceous gland progenitors.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Looking at tissue characteristics isn't reliable for telling apart basal cell carcinoma from certain benign skin tumors.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Scientists created a detailed map of gene activity in different parts of human hair follicles.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

Trichohyalin, a hair follicle protein, has a part with repeating patterns of 23 amino acids.

The ovine Hoxc-13 gene is crucial for hair formation and may have other skin functions.

The same gene mutation can cause different symptoms in family members.

Interleukin-6 may play a role in causing alopecia areata.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

A mutation in the iRhom2 gene causes hairless mice due to abnormal hair follicle development.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Estrogen receptors affect hair growth, with ER beta slowing down the hair cycle changes caused by ER alpha.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.